Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclopol ED50 for suppressing endotracheal intubation response
ChiCTR2500095959Phase 4Completed
- Sponsor
- Nanchong City Central Hospital
- Start
- Jan 2025
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ciprofol in None, sponsored by Nanchong City Central Hospital. Primary endpoints: Intubation response and Number of adverse reactions. Started Jan 2025; status: completed.
02
Drugs
ciprofol
Beyond the preview
Go deeper on ChiCTR2500095959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500095959.